Evidence map›Paper›PMID 35864102›Full record

ReviewNature reviews. Disease primers2022

Chronic wounds.

Vincent Falanga, Roslyn Rivkah Isseroff, Athena M Soulika, Marco Romanelli, David Margolis, Suzanne Kapp, Mark Granick, Keith Harding

Registry-linked trialAbstract readReview
In one paragraph

Review in Nature reviews. Disease primers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07745764 (INJECTHEAL- Profiling of Potential Wound Healing Therapeutics in Cellular Assays in the Presence of Wound Exudates), which is not on this map. Cited by 385 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
385citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07745764 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

INJECTHEAL- Profiling of Potential Wound Healing Therapeutics in Cellular Assays in the Presence of Wound Exudates

TypeobservationalSponsorBarbara Wolff-WiniskiRan2026 to 2028Enrolled72ConditionsChronic Ulcers: Non-healing Deep Cavity Wounds (e.g., Diabetic Foot Ulcers, Arterial Ulcers, Post-surgical Wound Healing Disorders)Armsstandard of care
3 · Its place in the literature

Who cites it

385 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Immunomodulatory Nanozymes as Programmable Redox-Immune Set-Point Regulators.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  17. Article
  18. Article
  19. Review
  20. Review

325 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vincent FalangaDepartment of Dermatology, Boston University, Boston, MA, USA. vfalanga@bu.edu.ORCID http://orcid.org/0000-0003-2292-2017
Roslyn Rivkah IsseroffDepartment of Dermatology, University of California at Davis, Davis, CA, USA.ORCID http://orcid.org/0000-0001-7813-0858
Athena M SoulikaDepartment of Dermatology, University of California at Davis, Davis, CA, USA.ORCID http://orcid.org/0000-0001-6746-3876
Marco RomanelliDepartment of Dermatology, University of Pisa, Pisa, Italy.
David MargolisDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-0506-8085
Suzanne KappDepartment of Nursing, University of Melbourne, Melbourne, Australia.ORCID http://orcid.org/0000-0002-5438-8384
Mark GranickDepartment of Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.
Keith HardingClinical Innovation Hub Cardiff University, Cardiff, Wales, UK.ORCID http://orcid.org/0000-0003-0048-3279

Funding

5-Lipoxygenase exerts dual and opposing functions during the wound healing processR01GM135279 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SOULIKA, ATHENA · 2020 to 2023
$1.5M
NIGMS NIH HHS R01 GM135279
6 · The paper itself

Abstract

Chronic wounds are characterized by their inability to heal within an expected time frame and have emerged as an increasingly important clinical problem over the past several decades, owing to their increasing incidence and greater recognition of associated morbidity and socio-economic burden. Even up to a few years ago, the management of chronic wounds relied on standards of care that were outdated. However, the approach to these chronic conditions has improved, with better prevention, diagnosis and treatment. Such improvements are due to major advances in understanding of cellular and molecular aspects of basic science, in innovative and technological breakthroughs in treatment modalities from biomedical engineering, and in our ability to conduct well-controlled and reliable clinical research. The evidence-based approaches resulting from these advances have become the new standard of care. At the same time, these improvements are tempered by the recognition that persistent gaps exist in scientific knowledge of impaired healing and the ability of clinicians to reduce morbidity, loss of limb and mortality. Therefore, taking stock of what is known and what is needed to improve understanding of chronic wounds and their associated failure to heal is crucial to ensuring better treatments and outcomes.

Indexed as

Wound HealingChronic DiseaseHumans

Identifiers

PMID35864102
PMCPMC10352385

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.